Voyager Acquisition Corp. (VACH)
| Market Cap | 328.11M |
| Revenue (ttm) | n/a |
| Net Income (ttm) | 6.63M |
| Shares Out | 31.63M |
| EPS (ttm) | 0.30 |
| PE Ratio | 35.10 |
| Forward PE | n/a |
| Dividend | n/a |
| Ex-Dividend Date | n/a |
| Volume | 5,172 |
| Open | 10.38 |
| Previous Close | 10.38 |
| Day's Range | 10.37 - 10.38 |
| 52-Week Range | 9.95 - 11.20 |
| Beta | n/a |
| Analysts | n/a |
| Price Target | n/a |
| Earnings Date | n/a |
About VACH
Voyager Acquisition Corp. does not have significant operations. It focuses on effecting a merger, share exchange, asset acquisition, share purchase, reorganization, or similar business combination with one or more businesses or entities. It intends to focus on businesses in the healthcare or healthcare related sectors. The company was incorporated in 2023 and is based in Brooklyn, New York. [Read more]
News
VERAXA Biotech to Attend Key Industry Conferences to Showcase BiTAC Technology Platform
VERAXA Attending ASCO and BIO with Cantor Fitzgerald, Voyager's Recently Retained Capital Markets Advisor, and Hosting Meetings with Potential Partners and Investors VERAXA Attending ASCO and BIO with...
VERAXA Biotech Appoints Rick Austin as Chief Scientific Officer
Industry Veteran to Support Acceleration of Key Pipeline Projects and Novel BiTAC™ Antibody Formats Towards Clinical Studies Industry Veteran to Support Acceleration of Key Pipeline Projects and Novel...
Voyager Acquisition Corp. Announces Pricing of $220,000,000 Initial Public Offering
Voyager Acquisition Corp. (Nasdaq: VACHU) announced today the pricing of its initial public offering of 22,000,000 units at $10.00 per unit.
Healthcare SPAC Voyager Acquisition files for a $261 million IPO
Voyager Acquisition, a blank check company targeting the healthcare sector, filed on Tuesday with the SEC to raise up to $261 million in an initial public offering.
Voyager Acquisition IPO Registration Document (S-1)
Voyager Acquisition has filed to go public with an IPO on the NASDAQ.